Schedule COVID-19 Vaccine | Walgreens (2024)

FAQs

What are the odds of getting long COVID with the vaccine? ›

19, 2021), the gap widened: 7.76 out of 100 unvaccinated people but only 3.5 out of 100 vaccinated people acquired long Covid. “Vaccines very clearly work, but also clearly, they don't totally wipe it out,” the study's senior author, Ziyad Al-Aly, said in an interview.

People 5 years and older may get one dose of the updated vaccine at least two months after the last dose of any previous COVID vaccine. Babies and young children usually need more doses than older children and teens.

The Moderna COVID-19 Vaccine (2023-2024 Formula) includes a monovalent (single) component that corresponds to the Omicron variant XBB. 1.5 of SARS-CoV-2.

Pfizer: Is There a “Best” mRNA Vaccine? Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Moderna's elicits a stronger immune response and might be better at preventing breakthrough infections.

Recap. The Pfizer-BioNTech vaccine offers protection against the original COVID-19 virus for up to six months.

For example, says Mallory Shillinger, D.O., a Piedmont primary care physician, vaccinated people often have “a fever for one or two days, along with fatigue, a sore throat and dry cough that can last three to five days. Also, a loss of taste and smell that can linger for two to three weeks.”

No matter which type of shot you get, your body breaks down the ingredients or they're destroyed by your immune system within a few days. This means vaccines can't cause long-lasting health effects.

The immune response from a COVID-19 infection usually tamps down after 3-4 months, says Kawsar Talaat, MD, a vaccinologist and associate professor in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins School of Medicine in Baltimore, Maryland.

Booster doses are recommended or can be considered based on your age and the presence of risk factors for severe illness. All adults are eligible for a booster dose every 12 months. Adults 65 years and over, or aged 18-64 who are severely immunocompromised, are eligible to receive a booster dose every 6 months.

Federal health experts have authorized a new 2024-25 COVID-19 vaccine that they hope will reduce deaths and hospitalizations among the most vulnerable people in the country.

How often should you get the bivalent booster? ›

Individuals 6 years and older with certain kinds of immunocompromise may receive an additional bivalent vaccine at least 2 months from their last bivalent dose. More than one booster dose may be eligible for certain populations.

On April 18, 2023, the FDA announced that the original Pfizer and Moderna COVID-19 vaccines are no longer authorized for use in the U.S. Instead, the bivalent (updated) version of the vaccines will be used for all vaccine doses.

A booster shot with the Moderna vaccine offered older people better protection against COVID-19 if they had previously taken Pfizer jabs, researchers at the National Centre for Infectious Diseases (NCID) have found.

In December 2020, Pfizer-BioNTech's Phase 3 clinical data for its original vaccine showed 95% efficacy for preventing symptomatic COVID.

Public health has also made it clear that it is safe to mix and match Pfizer and Moderna COVID vaccines for booster shots.

The most common symptoms were exercise intolerance reported by 170 (71%) participants, excessive fatigue by 167 (69%), numbness by 153 (63%), brain fog by 151 (63%), neuropathy by 151 (63%), insomnia by 148 (61%), palpitations by 145 (60%), myalgia by 132 (55%), tinnitus or humming in ears by 131 (54%), headache by 128 ...

Additionally, scientists discovered that long COVID was more likely to occur after a first infection compared to a reinfection. The study, funded by the National Institutes of Health's (NIH) Researching COVID to Enhance Recovery (RECOVER ) Initiative, is published in Communications Medicine .

As a precaution, the U.S. Food and Drug Administration (FDA) added a warning to patient and provider fact sheets. Overall, heart inflammation is an extremely rare side effect of the COVID-19 vaccine. In fact, heart inflammation is much more common if you get the COVID-19 virus.

Research shows that COVID-19 vaccination prior to SARS-CoV-2 infection reduces the risk of developing Long COVID among both children and adults.